News

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
Updates to Moderna and Pfizer's COVID shots for the new strain were approved ... Novavax's COVID-19 vaccine, which was expected to get full approval on April 1. Novavax said Monday that the FDA ...
On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...
Novavax's COVID vaccine was approved under an emergency use authorization in August 2022, and the company has pursued full ...
At the peak of the COVID-19 pandemic, many vaccine skeptics turned to ivermectin, a medication proven to fight off parasitic ...
The Department of Health and Human Services, which oversees FDA and other health agencies, did not immediately respond to a ...
"PMCs are not unusual with many approved drugs / biologics ... But with FDA action, it would be the third vaccine against COVID-19 to receive full FDA approval, which could provide additional ...